[artículo] 
inThe American Journal of Psychiatry > Año 2018 - Vol. 175 - No. 3 (Marzo) . - pp. 232-241

Título :	Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer’s Dementia in Individuals With Previous Depression
Tipo de documento:	texto impreso
Autores:	Claudia Bartels, Autor ; Michael Wagner, Autor ; Steffen Wolfsgruber, Autor
Fecha de publicación:	2018
Artículo en la página:	pp. 232-241
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Enfermedad demencia-Alzheimer, Demencia, Diagnosis, clasificación, Psiquiatría geriátrica, Psicoterapia
Resumen:	Depression is associated with an increased risk of Alzheimer’s disease. Research has shown that the selective serotonin reuptake inhibitor (SSRI) citalopram decreases amyloid-β generation and plaque load. The authors evaluated the impact of SSRI treatment on CSF biomarkers and progression from mild cognitive impairment (MCI) to Alzheimer’s dementia.
Link:	./index.php?lvl=notice_display&id=13297

[artículo] Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer’s Dementia in Individuals With Previous Depression [texto impreso] / Claudia Bartels, Autor ; Michael Wagner, Autor ; Steffen Wolfsgruber, Autor . - 2018 . - pp. 232-241.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2018 - Vol. 175 - No. 3 (Marzo) . - pp. 232-241

Palabras clave:	Enfermedad demencia-Alzheimer, Demencia, Diagnosis, clasificación, Psiquiatría geriátrica, Psicoterapia
Resumen:	Depression is associated with an increased risk of Alzheimer’s disease. Research has shown that the selective serotonin reuptake inhibitor (SSRI) citalopram decreases amyloid-β generation and plaque load. The authors evaluated the impact of SSRI treatment on CSF biomarkers and progression from mild cognitive impairment (MCI) to Alzheimer’s dementia.
Link:	./index.php?lvl=notice_display&id=13297